4//SEC Filing
HUSSAIN IQBAL J 4
Accession 0001847903-25-000137
CIK 0001847903other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 6:13 PM ET
Size
9.6 KB
Accession
0001847903-25-000137
Insider Transaction Report
Form 4
HUSSAIN IQBAL J
General Counsel
Transactions
- Sale
Ordinary Shares
2025-08-15$17.23/sh−6,000$103,380→ 105,386 total - Exercise/Conversion
Share Option (right to buy)
2025-08-15−6,000→ 279,559 totalExercise: $5.84Exp: 2031-02-19→ Ordinary Shares (6,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-08-15$5.84/sh+6,000$35,040→ 111,386 total
Holdings
- 5,500(indirect: By Spouse)
Ordinary Shares
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024.
- [F3]25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001862050
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 6:13 PM ET
- Size
- 9.6 KB